These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does antiviral therapy prevent recurrence of hepatitis B virus–related hepatocellular carcinoma after curative liver resection? Lok AS JAMA; 2012 Nov; 308(18):1922-24. PubMed ID: 23147511 [No Abstract] [Full Text] [Related]
5. [Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma]. Sun J; Zhang S; Wang YX; Zhu L; Xing HC Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):721-724. PubMed ID: 31594101 [TBL] [Abstract][Full Text] [Related]
6. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076 [TBL] [Abstract][Full Text] [Related]
7. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis. Xu J; Li J; Chen J; Liu ZJ Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368 [TBL] [Abstract][Full Text] [Related]
8. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm. Zhang ZY; Zhou ZQ; Zhou GW Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1116-24. PubMed ID: 25003747 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in the prevention of hepatocellular carcinoma recurrence. Lu LC; Cheng AL; Poon RT Semin Liver Dis; 2014 Nov; 34(4):427-34. PubMed ID: 25369304 [TBL] [Abstract][Full Text] [Related]
10. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: the lower, the better! You H; Jia JD J Gastroenterol Hepatol; 2010 Dec; 25(12):1812-4. PubMed ID: 21091989 [No Abstract] [Full Text] [Related]
12. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [TBL] [Abstract][Full Text] [Related]
13. Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma. Qu LS; Jin F; Huang XW; Shen XZ J Surg Oncol; 2010 Dec; 102(7):796-801. PubMed ID: 20886584 [TBL] [Abstract][Full Text] [Related]
14. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. Sohn W; Kang TW; Choi SK; Jung SH; Lee MW; Lim HK; Cho JY; Shim SG; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Rhim H; Paik YH Oncotarget; 2016 Jul; 7(30):47794-47807. PubMed ID: 27329596 [TBL] [Abstract][Full Text] [Related]
15. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia. Sherman KE; Shah VH Gastroenterology; 2018 Feb; 154(3):453-456. PubMed ID: 29154778 [No Abstract] [Full Text] [Related]
16. How does hepatitis B virus infection react to hepatocellular carcinoma treatment? Wong GL J Gastroenterol Hepatol; 2012 Jan; 27(1):1-2. PubMed ID: 22188022 [No Abstract] [Full Text] [Related]
17. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Li N; Lai EC; Shi J; Guo WX; Xue J; Huang B; Lau WY; Wu MC; Cheng SQ Ann Surg Oncol; 2010 Jan; 17(1):179-85. PubMed ID: 19727956 [TBL] [Abstract][Full Text] [Related]
18. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report. Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070 [TBL] [Abstract][Full Text] [Related]
19. Preventing infection-associated cancer: from bench to hillside. Goedert JJ J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953 [No Abstract] [Full Text] [Related]
20. [Ratio analysis of HBV-related liver disease and primary liver carcinoma development over 10 years in patients who received no antiviral therapy versus those treated with antiviral therapy]. Huo H; Ren S; Wang S; Xu Y; Ma L; Liu Y; Jin Y; Zheng Y; Chen X Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):68-70. PubMed ID: 24754089 [No Abstract] [Full Text] [Related] [Next] [New Search]